{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:48:57Z","timestamp":1761824937218,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T00:00:00Z","timestamp":1709424000000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.advms.2024.03.001","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T19:15:27Z","timestamp":1709406927000},"page":"125-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of intensity-modulated radiotherapy combined with chemotherapy and prognostic factors in patients with locally advanced oesophageal cancer"],"prefix":"10.1016","volume":"69","author":[{"given":"Yao","family":"Ou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Suo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.advms.2024.03.001_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","article-title":"Global burden of 5 major types of gastrointestinal cancer","volume":"159","author":"Arnold","year":"2020","journal-title":"Gastroenterology"},{"issue":"10184","key":"10.1016\/j.advms.2024.03.001_bib2","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"Al-Batran","year":"2019","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.advms.2024.03.001_bib3","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"Lancet Oncol"},{"issue":"22","key":"10.1016\/j.advms.2024.03.001_bib4","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.advms.2024.03.001_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40880-019-0368-6","article-title":"Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?","volume":"39","author":"Feng","year":"2019","journal-title":"Cancer Commun"},{"issue":"5","key":"10.1016\/j.advms.2024.03.001_bib6","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41416-021-01485-9","article-title":"Advances in the curative management of oesophageal cancer","volume":"126","author":"Bolger","year":"2022","journal-title":"Br J Cancer"},{"issue":"17","key":"10.1016\/j.advms.2024.03.001_bib7","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1001\/jama.281.17.1623","article-title":"Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group","volume":"281","author":"Cooper","year":"1999","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.advms.2024.03.001_bib8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/01.JTO.0000275339.62831.5e","article-title":"Radiochemotherapy of esophageal cancer","volume":"2","author":"Liao","year":"2007","journal-title":"J\u00a0Thorac Oncol : Offic Publ Int Assoc Study Lung Cancer"},{"issue":"5","key":"10.1016\/j.advms.2024.03.001_bib9","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the radiation therapy Oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.advms.2024.03.001_bib10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.advms.2024.03.001_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jtho.2016.10.016","article-title":"Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer","volume":"12","author":"Rice","year":"2017","journal-title":"J\u00a0Thorac Oncol : Offic Publ Int Assoc Study Lung Cancer"},{"issue":"1 Suppl","key":"10.1016\/j.advms.2024.03.001_bib12","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1067\/msy.2002.119308","article-title":"Clinical application of hyperthermia combined with anticancer drugs for the treatment of solid tumors","volume":"131","author":"Takahashi","year":"2002","journal-title":"Surgery"},{"issue":"10","key":"10.1016\/j.advms.2024.03.001_bib13","doi-asserted-by":"crossref","first-page":"873","DOI":"10.5732\/cjc.010.10165","article-title":"Literature analysis of radiotherapy for esophageal cancer in China","volume":"29","author":"Zhou","year":"2010","journal-title":"Chin J Cancer"},{"issue":"12","key":"10.1016\/j.advms.2024.03.001_bib14","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1111\/1759-7714.13971","article-title":"Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a propensity score-matched analysis","volume":"12","author":"Li","year":"2021","journal-title":"Thoracic Cancer"},{"issue":"1","key":"10.1016\/j.advms.2024.03.001_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/1759-7714.12536","article-title":"Feasibility and efficiency of concurrent chemoradiotherapy with capecitabine and cisplatin versus radiotherapy alone for elderly patients with locally advanced esophageal squamous cell carcinoma: experience of two centers","volume":"9","author":"Chen","year":"2018","journal-title":"Thoracic Cancer"},{"issue":"1","key":"10.1016\/j.advms.2024.03.001_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s13014-018-1183-y","article-title":"Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for stage IV esophageal squamous cell carcinoma: a retrospective controlled study","volume":"13","author":"Lyu","year":"2018","journal-title":"Radiat Oncol"},{"issue":"20","key":"10.1016\/j.advms.2024.03.001_bib17","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1200\/JCO.18.02122","article-title":"Comparing paclitaxel plus fluorouracil versus cisplatin plus fluorouracil in chemoradiotherapy for locally advanced esophageal squamous cell cancer: a randomized, multicenter, phase III clinical trial","volume":"37","author":"Chen","year":"2019","journal-title":"J\u00a0Clin Oncol : official journal of the American Society of Clinical Oncology"},{"issue":"1","key":"10.1016\/j.advms.2024.03.001_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13014-021-01931-1","article-title":"Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma","volume":"16","author":"Wu","year":"2021","journal-title":"Radiat Oncol"},{"issue":"25","key":"10.1016\/j.advms.2024.03.001_bib19","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1200\/JCO.20.03697","article-title":"Randomized study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer (ARTDECO study)","volume":"39","author":"Hulshof","year":"2021","journal-title":"J\u00a0Clin Oncol : official journal of the American Society of Clinical Oncology"},{"issue":"5","key":"10.1016\/j.advms.2024.03.001_bib20","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ijrobp.2016.08.016","article-title":"Radiation dose escalation in esophageal cancer revisited: a contemporary analysis of the national cancer data Base, 2004 to 2012","volume":"96","author":"Brower","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.advms.2024.03.001_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dow037","article-title":"Dose escalation of definitive radiation is not associated with improved survival for cervical esophageal cancer: a National Cancer Data Base (NCDB) analysis","volume":"30","author":"De","year":"2017","journal-title":"Dis Esophagus : Offic J Int Soc Diseases Esophagus"},{"issue":"34","key":"10.1016\/j.advms.2024.03.001_bib22","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.3748\/wjg.v12.i34.5501","article-title":"Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer","volume":"12","author":"Wang","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"20","key":"10.1016\/j.advms.2024.03.001_bib23","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1158\/1078-0432.CCR-12-0858","article-title":"Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy","volume":"18","author":"Meijer","year":"2012","journal-title":"Clin Cancer Res : Offi J Am Assoc Cancer Res"},{"issue":"6","key":"10.1016\/j.advms.2024.03.001_bib24","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/01.coc.0000242346.25229.48","article-title":"Tumor volume as outcome determinant in patients treated with chemoradiation for locally advanced esophageal cancer","volume":"29","author":"Cr\u00e9hange","year":"2006","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"10.1016\/j.advms.2024.03.001_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12029-015-9699-y","article-title":"Primary gross tumor volume is an important prognostic factor in locally advanced esophageal cancer patients treated with trimodality therapy","volume":"46","author":"Boggs","year":"2015","journal-title":"J\u00a0Gastrointest Cancer"},{"issue":"1","key":"10.1016\/j.advms.2024.03.001_bib26","first-page":"e1425","article-title":"Randomized trial on acute toxicities of weekly vs three-weekly cisplatin-based chemoradiation in head and neck cancer","volume":"5","author":"Ameri","year":"2022","journal-title":"Cancer Rep"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112624000142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112624000142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:44:29Z","timestamp":1761824669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112624000142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1896112624000142"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2024.03.001","relation":{},"ISSN":["1896-1126"],"issn-type":[{"type":"print","value":"1896-1126"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of intensity-modulated radiotherapy combined with chemotherapy and prognostic factors in patients with locally advanced oesophageal cancer","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2024.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Medical University of Bialystok.","name":"copyright","label":"Copyright"}]}}